The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Escherichia infection 5
SANDOSTATIN LAR DEPOT Eye haemorrhage 5
SANDOSTATIN LAR DEPOT Facial pain 5
SANDOSTATIN LAR DEPOT Faecal volume increased 5
SANDOSTATIN LAR DEPOT Feeling of body temperature change 5
SANDOSTATIN LAR DEPOT Foot deformity 5
SANDOSTATIN LAR DEPOT Gastric ulcer 5
SANDOSTATIN LAR DEPOT Haemoptysis 5
SANDOSTATIN LAR DEPOT Helicobacter infection 5
SANDOSTATIN LAR DEPOT Hepatomegaly 5
SANDOSTATIN LAR DEPOT Hypokalaemia 5
SANDOSTATIN LAR DEPOT Hypomagnesaemia 5
SANDOSTATIN LAR DEPOT Impatience 5
SANDOSTATIN LAR DEPOT Inguinal hernia 5
SANDOSTATIN LAR DEPOT Injection site discolouration 5
SANDOSTATIN LAR DEPOT Injection site injury 5
SANDOSTATIN LAR DEPOT Intervertebral disc protrusion 5
SANDOSTATIN LAR DEPOT Intestinal perforation 5
SANDOSTATIN LAR DEPOT Jaw disorder 5
SANDOSTATIN LAR DEPOT Language disorder 5

Total Records: 2,045     Number of Pages: 103